Careology is delighted to announce our innovative new partnership with LloydsPharmacy Clinical Homecare, a leading provider of home chemotherapy and part of McKesson UK.
This new approach to cancer care is for the first-time enabling clinicians, oncology nurses and carers to remotely monitor patients undergoing treatment at home. Using the Careology app on the patient’s phone or tablet device, which communicates with off-the-shelf wearable tech devices, clinicians are now able to see their patients’ symptoms, side effects, medication adherence and a range of other biometrics remotely.
The platform empowers patients, enabling them to confidently receive treatment in the comfort of their homes while allowing nurses and consultants to remotely monitor their patients. The new technology is designed to significantly enhance the quality of care provided, as well as deliver a better patient experience and improve health outcomes.
The Careology technology, specifically designed for cancer care, is the first of its kind in the UK and recommended by Macmillan Cancer Support. With cancer waiting times currently at record levels because of Covid-19, it has the potential to change the way cancer care is administered and offers a model for future innovation – digitalising paperwork, taking more people out of hospital and freeing up nurses to offer care where and when it is most needed.
Joanne Upton, Deputy Head of Nursing of LloydsPharmacy Clinical Homecare, said:
“Receiving cancer treatment is an incredibly challenging experience. We believe that having chemotherapy, delivered one-on-one by an experienced nurse in the comfort of your own home, coupled with the enhanced care and safety the platform provides, would make such a difference to our patients' lives.”
We are always looking at meaningful ways to improve the experience for our patients and their families. Equipping those undergoing treatment with new technology will give our nurses greater insight into how their patients are coping. It also empowers those they care for to self-manage in between treatment, promote their safety and overall well-being.”
Careology was founded by Paul Landau, a health-tech entrepreneur, whose experience of caring for a family member with cancer inspired him to develop the system.
Paul Landau, Founder and CEO of Careology, said:
“Technology has a crucial role to play in helping healthcare providers deliver effective, scalable cancer care, whilst enhancing patient safety and improving the patient experience. Having instant access to this in depth, real-time information will provide consultants with greater confidence when referring their patients to receive treatment at home and outside of a hospital setting.
This hybrid model of homecare and digital cancer care is truly transformative; we expect to demonstrate that it creates capacity and is also cost-effective, reducing drug wastage and unexpected acute hospital admissions.”
Dany Bell, Strategic Advisor to Macmillan said:
“The current pandemic has had a devastating impact on cancer services around the UK. Disruption to diagnosis and treatment have created significant challenges for patients and healthcare professionals. Finding ways to better support people living with cancer whilst establishing continuity of care is crucial now and in the future.”
Dr Verna Lavender, President UK Oncology Nursing Society said:
"During the recent pandemic, cancer nurses have significantly increased their use of digital technology to monitor and communicate with patients within patients' own homes. When used in partnership between patients and specialist cancer nurses to aid communication and monitoring, evidence-based symptom and side-effect reporting apps can enhance the experiences and outcomes of patients with cancer who are motivated and able to safely manage their own care at home."